Source: Eur Respir J, 55 (1) 1901113; 10.1183/13993003.01113-2019
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hartmut Grasemann, Michelle Klingel, Julie Avolio, Carley Prentice, Tanja Gonska, Elizabeth Tullis, Felix Ratjen. Long-term effect of CFTR modulator therapy on airway nitric oxide. Eur Respir J, 55 (1) 1901113; 10.1183/13993003.01113-2019

Member's Comments

No comment yet.

Related content which might interest you: Acinar effect of inhaled steroids therapy evidenced by exhaled nitric oxide Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001 The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs Source: ERJ Open Res 2016 Year: 2016 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020 Salbutamol temporarily increases the bronchial production of nitric oxide Source: Eur Respir J 2007; 30: Suppl. 51, 63s Year: 2007 Nitric oxide is a poor bronchodilator but reduces release of leukotrienes in the peripheral airways Source: Eur Respir J 2005; 26: Suppl. 49, 128s Year: 2005 Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002 Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Predicting response to corticosteroid in COPD using exhaled nitric oxide Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 429s Year: 2004 Reduced bronchial nitric oxide flux but unchanged alveolar nitric oxide concentration after exposure to hyperbaric hyperoxia Source: Annual Congress 2010 - New diagnostic approaches in respiratory function Year: 2010 Nasal nitric oxide Source: Eur Respir Monogr 2010; 49: 71-81 Year: 2010 Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Long-term variation of exhaled nitric oxide Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005 The role of nitric oxide (NO) on sepsis-induced pulmonary apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 358s Year: 2001